Hormone Receptor Positive Breast Neoplasms
3 clinical trials · Condition
◉ Watch Hormone Receptor Positive Breast Neoplasms
| Record | Firm | Date |
|---|---|---|
| A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors (NCT05194072) | Seagen, a wholly owned subsidiary of Pfizer | 2022-01-12 |
| A Safety Study of SGN-LIV1A in Breast Cancer Patients (NCT01969643) | Seagen Inc. | 2013-10-22 |
Track Hormone Receptor Positive Breast Neoplasms automatically
Every clearance here is in the API, with alerts when new ones post.